107
Views
1
CrossRef citations to date
0
Altmetric
Special Issue Articles

The Need to Consider Context: A Systematic Review of Factors Involved in the Consent Process for Genetic Tests from the Perspective of Patients

&

References

  • Alderfer, M. A., K. Zelley, R. B. Lindell, A. Novokmet, P. L. Mai, J. E. Garber, D. Nathan, S. Scollon, N. M. Chun, A. F. Patenaude, et al. 2015. Parent decision-making around the genetic testing of children for germline TP53 mutations. Cancer 121 (2):286–93. doi:10.1002/cncr.29027.
  • Allford, A., N. Qureshi, J. Barwell, C. Lewis, and J. Kai. 2014. What hinders minority ethnic access to cancer genetics services and what may help? European Journal of Human Genetics 22 (7):866–74. doi:10.1038/ejhg.2013.257.
  • Ames, A. G., S. A. Metcalfe, A. Dalton Archibald, R. E. Duncan, and J. Emery. 2015. Measuring informed choice in population-based reproductive genetic screening: A systematic review. European Journal of Human Genetics 23 (1):8–21. doi:10.1038/ejhg.2014.89.
  • Ames, A. G., A. Jaques, O. C. Ukoumunne, A. D. Archibald, R. E. Duncan, J. Emery, and S. A. Metcalfe. 2015a. Development of a fragile X syndrome (FXS) knowledge scale: Towards a modified multidimensional measure of informed choice for FXS population carrier screening. Health Expectations 18 (1):69–80. doi:10.1111/hex.12009.
  • Anderson, J. A., M. S. Meyn, C. Shuman, R. Zlotnik Shaul, L. E. Mantella, M. J. Szego, S. Bowdin, N. Monfared, and R. Z. Hayeems. 2017. Parents perspectives on whole genome sequencing for their children: Qualified enthusiasm? Journal of Medical Ethics 43 (8):535–9. doi:10.1136/medethics-2016-103564.
  • Anderson, K. E., S. Eberly, K. S. Marder, D. Oakes, E. Kayson, A. Young, and I. Shoulson. 2019. The choice not to undergo genetic testing for Huntington disease: Results from the PHAROS study. Clinical Genetics 96 (1):28–34. doi:10.1111/cge.13529.
  • Bekker, H. L., J. Hewison, and J. G. Thornton. 2004. Applying decision analysis to facilitate informed decision making about prenatal diagnosis for Down syndrome: A randomised controlled trial. Prenatal Diagnosis 24 (4):265–75. doi:10.1002/pd.851.
  • Bluman, L. G., B. K. Rimer, K. Regan Sterba, J. Lancaster, S. Clark, N. Borstelmann, J. D. Iglehart, and E. P. Winer. 2003. Attitudes, knowledge, risk perceptions and decision-making among women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2 and their spouses. Psycho-oncology 12 (5):410–27. doi:10.1002/pon.653.
  • Bosompra, K., T. Ashikaga, B. S. Flynn, J. K. Worden, and L. J. Solomon. 2001. Psychosocial factors associated with the public’s willingness to pay for genetic testing for cancer risk: A structural equations model. Health Education Research 16 (2):157–72. doi:10.1093/her/16.2.157.
  • Botoseneanu, A., J. A. Alexander, and J. Banaszak-Holl. 2011. To test or not to test? The role of attitudes, knowledge, and religious involvement among U.S. adults on intent-to-obtain adult genetic testing. Health Education & Behavior 38 (6):617–28. doi:10.1177/1090198110389711.
  • Browner, C. H., and H. M. Preloran. 2004. Expectations, emotions, and medical decision making: A case study on the use of amniocentesis. Transcultural Psychiatry 41 (4):427–44. doi:10.1177/1363461504045646.
  • Calonico, E., Y. J. Blumenfeld, L. Hudgins, and J. Taylor. 2016. Patient preferences for prenatal testing of microdeletion and microduplication syndromes. Prenatal Diagnosis 36 (3):244–51. doi:10.1002/pd.4760.
  • Cameron, L. D., and J. Reeve. 2006. Risk perceptions, worry, and attitudes about genetic testing for breast cancer susceptibility. Psychology & Health 21 (2):211–30. doi:10.1080/14768320500230318.
  • Cappelli, M., L. Surh, M. Walker, Y. Korneluk, L. Humphreys, S. Verma, A. Hunter, J. Allanson, and D. Logan. 2001. Psychological and social predictors of decisions about genetic testing forbreast cancer in high-Risk women. Psychology, Health and Medicine 6 (3):321–33. doi:10.1080/13548500123484.
  • Carroll, F. E., A. Owen-Smith, A. Shaw, and A. A. Montgomery. 2012. A qualitative investigation of the decision-making process of couples considering prenatal screening for Down syndrome. Prenatal Diagnosis 32 (1):57–63. doi:10.1002/pd.2901.
  • Cernat, A., C. De Freitas, U. Majid, F. Trivedi, C. Higgins, and M. Vanstone. 2019. Facilitating informed choice about non-invasive prenatal testing (NIPT): A systematic review and qualitative meta-synthesis of women’s experiences. BMC Pregnancy and Childbirth 19 (1):27. doi:10.1186/s12884-018-2168-4.
  • Chen, A., H. Tenhunen, P. Torkki, A. Peltokorpi, S. Heinonen, P. Lillrank, and V. Stefanovic. 2018. Facilitating autonomous, confident and satisfying choices: A mixed-method study of women’s choice-making in prenatal screening for common aneuploidies. BMC Pregnancy and Childbirth 18 (1):119. doi:10.1186/s12884-018-1752-y.
  • Chen, L. S., and P. Goodson. 2007. Factors affecting decisions to accept or decline cystic fibrosis carrier testing/screening: A theory-guided systematic review. Genetics in Medicine 9 (7):442–50. doi:10.1097/gim.0b013e3180986767.
  • Chen, L. S., L. Xu, S. U. Dhar, M. Li, D. Talwar, and E. Jung. 2015. Autism spectrum disorders: A qualitative study of attitudes toward prenatal genetic testing and termination decisions of affected pregnancies. Clinical Genetics 88 (2):122–8. doi:10.1111/cge.12504.
  • Chen, L. S., L. Xu, T. Y. Huang, and S. U. Dhar. 2013. Autism genetic testing: A qualitative study of awareness, attitudes, and experiences among parents of children with autism spectrum disorders. Genetics in Medicine 15 (4):274–81. doi:10.1038/gim.2012.145.
  • Chen, M. M., and B. H. Cheng. 2020. Understanding Taiwanese women’s decisional experiences regarding prenatal screening procedures and diagnostics: A phenomenological study. Asian Nursing Research 14 (4):231–40. doi:10.1016/j.anr.2020.08.005.
  • Chieng, W.-S, and S.-C. Lee. 2006. Establishing a cancer genetics programme in Asia – The Singapore experience. Hereditary Cancer in Clinical Practice 4 (3):126–35. doi:10.1186/1897-4287-4-3-126.
  • Chieng, W.-S, and S.-C. Lee. 2012. Discrepancy between initial high expression of interest in clinical cancer genetic testing and actual low uptake in an Asian Population. Genetic Testing and Molecular Biomarkers 16 (7):785–93. doi:10.1089/gtmb.2011.0268.
  • Clark, S., L. G. Bluman, N. Borstelmann, K. Regan, E. P. Winer, B. K. Rimer, and C. S. Skinner. 2000. Patient motivation, satisfaction, and coping in genetic counseling and testing for BRCA1 and BRCA2. Journal of Genetic Counseling 9 (3):219–35. doi:10.1023/A:1009463905057.
  • Codori, A. M., G. M. Petersen, D. L. Miglioretti, E. K. Larkin, M. T. Bushey, C. Young, J. D. Brensinger, K. Johnson, J. A. Bacon, and S. V. Booker. 1999. Attitudes toward colon cancer gene testing: Factors predicting test uptake. Cancer Epidemiology, Biomarkers & Prevention 8 (4 Pt 2):345–51.
  • Dane, A. C., M. Peterson, and Y. D. Miller. 2018. Talking points: Women’s information needs for informed decision-making about noninvasive prenatal testing for down syndrome. Journal of Genetic Counseling 27 (5):1258–64. doi:10.1007/s10897-018-0250-8.
  • Derks-Smeets, I. A., J. J. Gietel-Habets, A. Tibben, V. C. Tjan-Heijnen, M. Meijer-Hoogeveen, J. P. Geraedts, R. van Golde, E. Gomez-Garcia, E. van den Bogaart, M. van Hooijdonk, et al. 2014. Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: A challenge for couples with hereditary breast and ovarian cancer. Human Reproduction 29 (5):1103–12. doi:10.1093/humrep/deu034.
  • Etchegary, H., S. G. Nicholls, L. Tessier, C. Simmonds, B. K. Potter, J. C. Brehaut, D. Pullman, R. Hayeems, S. Zelenietz, M. Lamoureux, et al. 2016. Consent for newborn screening: Parents’ and health-care professionals’ experiences of consent in practice. European Journal of Human Genetics 24 (11):1530–4. doi:10.1038/ejhg.2016.55.
  • Etchegary, H. 2004. Psychological aspects of predictive genetic-test decisions: What do we know so far? Analyses of Social Issues and Public Policy 4 (1):13–31. doi:10.1111/j.1530-2415.2004.00032.x.
  • Fogel, A. L., P. D. Jaju, S. Li, B. Halpern-Felsher, J. Y. Tang, and K. Y. Sarin. 2017. Factors influencing and modifying the decision to pursue genetic testing for skin cancer risk. Journal of the American Academy of Dermatology 76 (5):829–35.e1. doi:10.1016/j.jaad.2016.11.050.
  • Fraint, A., B. Ouyang, L. V. Metman, C. Jones, D. A. Hall, K. Marder, and G. Pal. 2019. Patient knowledge and attitudes towards genetic testing in Parkinson’s disease subjects with deep brain stimulation. Parkinson’s Disease 2019:3494609. doi:10.1155/2019/3494609.
  • France, E. F., S. Wyke, S. Ziebland, V. A. Entwistle, and K. Hunt. 2011. How personal experiences feature in women’s accounts of use of information for decisions about antenatal diagnostic testing for foetal abnormality. Social Science & Medicine 72 (5):755–62. doi:10.1016/j.socscimed.2010.11.031.
  • French, B. N., T. W. Kurczynski, M. T. Weaver, and M. J. Pituch. 1992. Evaluation of the Health Belief Model and decision making regarding amniocentesis in women of advanced maternal age. Health Education Quarterly 19 (2):177–86. doi:10.1177/109019819201900203.
  • Gebhart, M. B., R. S. Hines, A. Penman, and A. C. Holland. 2016. How do patient perceived determinants influence the decision-making process to accept or decline preimplantation genetic screening? Fertility and Sterility 105 (1):188–93. doi:10.1016/j.fertnstert.2015.09.022.
  • Genoff Garzon, M. C., L. R. Rubin, M. Lobel, J. Stelling, and L. M. Pastore. 2018. Review of patient decision-making factors and attitudes regarding preimplantation genetic diagnosis. Clinical Genetics 94 (1):22–42. | doi:10.1111/cge.13174.
  • Gilmore, M. J., J. Schneider, J. V. Davis, T. L. Kauffman, M. C. Leo, K. Bergen, J. A. Reiss, P. Himes, E. Morris, C. Young, et al. 2017. Reasons for declining preconception expanded carrier screening using genome sequencing. Journal of Genetic Counseling 26 (5):971–9. doi:10.1007/s10897-017-0074-y.
  • Glenn, B. A., N. Chawla, and R. Bastani. 2012. Barriers to genetic testing for breast cancer risk among ethnic minority women: An exploratory study. Ethnicity and Disease 22 (3):267–73.
  • Gordon, E. J., D. Amórtegui, I. Blancas, C. Wicklund, J. Friedewald, and R. R. Sharp. 2019. A Focus Group Study on African american living donors’ treatment preferences, sociocultural factors, and health beliefs about apolipoprotein L1 genetic testing. Progress in Transplantation 29 (3):239–47. doi:10.1177/1526924819854485.
  • Hanish, A. E., M. Z. Cohen, and L. J. Starr. 2018. Autism spectrum disorder and genetic testing: Parental perceptions and decision-making. Journal for Specialists in Pediatric Nursing 23 (2):e12211. doi:10.1111/jspn.12211.
  • Hann, K. E. J., M. Freeman, L. Fraser, J. Waller, S. C. Sanderson, B. Rahman, L. Side, S. Gessler, and A. Lanceley. 2017. Awareness, knowledge, perceptions, and attitudes towards genetic testing for cancer risk among ethnic minority groups: A systematic review. BMC Public Health 17 (1):503. doi:10.1186/s12889-017-4375-8.
  • Hay, J. L., K. Meyer White, A. Sussman, K. Kaphingst, D. Guest, E. Schofield, Y. T. Dailey, E. Robers, M. R. Schwartz, K. Zielaskowski, et al. 2019. Psychosocial and cultural determinants of interest and uptake of skin cancer genetic testing in diverse primary care. Public Health Genomics 22 (1–2):58–68. doi:10.1159/000501985.
  • Helmes, A. W. 2002. Application of the protection motivation theory to genetic testing for breast cancer risk. Preventive Medicine 35 (5):453–62. doi:10.1006/pmed.2002.1110.
  • Henneman, L., D. R. Timmermans, C. M. Bouwman, M. C. Cornel, and H. Meijers-Heijboer. 2011. A low risk is still a risk’: exploring women’s attitudes towards genetic testing for breast cancer susceptibility in order to target disease prevention. Public Health Genomics 14 (4–5):238–47. doi:10.1159/000276543.
  • Hughes, C., G. A. Fasaye, V. H. LaSalle, and C. Finch. 2003. Sociocultural influences on participation in genetic risk assessment and testing among African American women. Patient Education and Counseling 51 (2):107–14. doi:10.1016/s0738-3991(02)00179-9.
  • Hunt, L. M., H. Castañeda, and K. B. DE Voogd. 2006. Do notions of risk inform patient choice? Lessons from a study of prenatal genetic counseling. Medical Anthropology 25 (3):193–219. doi:10.1080/01459740600829720.
  • Hunt, L. M., K. B. de Voogd, and H. Castañeda. 2005. The routine and the traumatic in prenatal genetic diagnosis: Does clinical information inform patient decision-making? Patient Education and Counseling 56 (3):302–12. doi:10.1016/j.pec.2004.03.004.
  • Huyard, C. 2012. Decision-making after prenatal diagnosis of a syndrome predisposing to intellectual disability: What prospective parents need to know and the importance of non-medical information. Journal of Intellectual & Developmental Disability 37 (4):315–23. doi:10.3109/13668250.2012.726350.
  • Ioannou, L., B. J. McClaren, J. Massie, S. Lewis, S. A. Metcalfe, L. Forrest, and M. B. Delatycki. 2014. Population-based carrier screening for cystic fibrosis: A systematic review of 23 years of research. Genetics in Medicine 16 (3):207–16. doi:10.1038/gim.2013.125.
  • Irwig, L., K. McCaffery, G. Salkeld, and P. Bossuyt. 2006. Screening and choice – Informed choice for screening: Implications for evaluation. BMJ 332 (7550):1148–50. doi:10.1136/bmj.332.7550.1148.
  • Jacobsen, P. B., H. B. Valdimarsdottier, K. L. Brown, and K. Offit. 1997. Decision-making about genetic testing among women at familial risk for breast cancer. Psychosomatic Medicine 59 (5):459–66. doi:10.1097/00006842-199709000-00001.
  • Jepson, R. G., J. Hewison, A. G. Thompson, and D. Weller. 2005. How should we measure informed choice? The case of cancer screening. Journal of Medical Ethics 31 (4):192–6. doi:10.1136/jme.2003.005793.
  • Kasparian, N. A., B. Meiser, P. N. Butow, J. M. Simpson, and G. J. Mann. 2009. Genetic testing for melanoma risk: A prospective cohort study of uptake and outcomes among Australian families. Genetics in Medicine 11 (4):265–78. doi:10.1097/GIM.0b013e3181993175.
  • Katapodi, M. C., M. L. Munro, P. F. Pierce, and R. A. Williams. 2011. Psychometric testing of the decisional conflict scale: Genetic testing hereditary breast and ovarian cancer. Nursing Research 60 (6):368–77. doi:10.1097/NNR.0b013e3182337dad.
  • Keogh, L. A., C. M. van Vliet, D. M. Studdert, J. A. Maskiell, F. A. Macrae, D. J. St John, C. L. Gaff, M. A. Young, M. C. Southey, G. G. Giles, et al. 2009. Is uptake of genetic testing for colorectal cancer influenced by knowledge of insurance implications? The Medical Journal of Australia 191 (5):255–8. doi:10.5694/j.1326-5377.2009.tb02778.x.
  • Kessler, L., A. Collier, K. Brewster, C. Smith, B. Weathers, E. P. Wileyto, and C. H. Halbert. 2005. Attitudes about genetic testing and genetic testing intentions in African American women at increased risk for hereditary breast cancer. Genetics in Medicine 7 (4):230–8. doi:10.1097/01.gim.0000159901.98315.fe.
  • Kieran, S., L. J. Loescher, and K. H. Lim. 2007. The role of financial factors in acceptance of clinical BRCA genetic testing. Genetic Testing 11 (1):101–10. doi:10.1089/gte.2006.9999.
  • Kobelka, C., A. Mattman, and S. Langlois. 2009. An evaluation of the decision-making process regarding amniocentesis following a screen-positive maternal serum screen result. Prenatal Diagnosis 29 (5):514–9. doi:10.1002/pd.2235.
  • Kuppermann, M., L. A. Learman, E. Gates, S. E. Gregorich, R. F. Nease, Jr, J. Lewis, and A. E. Washington. 2006. Beyond race or ethnicity and socioeconomic status: Predictors of prenatal testing for Down syndrome. Obstetrics and Gynecology 107 (5):1087–97. doi:10.1097/01.AOG.0000214953.90248.db.
  • Lacour, R. A., M. S. Daniels, S. N. Westin, L. A. Meyer, C. C. Burke, K. A. Burns, S. Kurian, N. F. Webb, T. B. Pustilnik, and K. H. Lu. 2008. What women with ovarian cancer think and know about genetic testing. Gynecologic Oncology 111 (1):132–6. doi:10.1016/j.ygyno.2008.06.016.
  • Learman, L. A., M. Kuppermann, E. Gates, R. F. Nease, Jr, V. Gildengorin, and A. E. Washington. 2003. Social and familial context of prenatal genetic testing decisions: Are there racial/ethnic differences? American Journal of Medical Genetics. Part C, Seminars in Medical Genetics 119C (1):19–26. doi:10.1002/ajmg.c.10004.
  • Lerman, C., and R. Croyle. 1994. Psychological issues in genetic testing for breast cancer susceptibility. Archives of Internal Medicine 154 (6):609–16. doi:10.1001/archinte.1994.00420060027003.
  • Lerman, C., M. Daly, A. Masny, and A. Balshem. 1994. Attitudes about genetic testing for breast-ovarian cancer susceptibility. Journal of Clinical Oncology 12 (4):843–50. doi:10.1200/JCO.1994.12.4.843.
  • Lerman, C., J. Seay, A. Balshem, and J. Audrain. 1995. Interest in genetic testing among first-degree relatives of breast cancer patients. American Journal of Medical Genetics 57 (3):385–92. doi:10.1002/ajmg.1320570304.
  • Lesperance, M. M., E. Winkler, T. L. Melendez, and B. M. Yashar. 2018. “My plate is full": Reasons for declining a genetic evaluation of hearing loss. Journal of Genetic Counseling 27 (3):597–607. doi:10.1007/s10897-017-0149-9. Epub 2017 Oct 4.
  • Lewis, C., M. Hill, and L. S. Chitty. 2016. A qualitative study looking at informed choice in the context of non-invasive prenatal testing for aneuploidy. Prenatal Diagnosis 36 (9):875–81. doi:10.1002/pd.4879.
  • Liamputtong, P., J. L. Halliday, R. Warren, F. Watson, and R. J. Bell. 2003. Why do women decline prenatal screening and diagnosis? Australian women’s perspective. Women & Health 37 (2):89–108. doi:10.1300/J013v37n02_06.
  • Lim, Q., B. C. McGill, V. F. Quinn, K. M. Tucker, D. Mizrahi, A. F. Patenaude, M. Warby, R. J. Cohn, and C. E. Wakefield. 2017. Parents’ attitudes toward genetic testing of children for health conditions: A systematic review. Clinical Genetics 92 (6):569–78. doi:10.1111/cge.12989.
  • Luksic, D., R. Sukhu, C. Koval, M. T. Cho, A. Espinal, K. Rufino, T. V. Loarte, W. K. Chung, and J. Wynn. 2020. A qualitative study of Latinx parents’ experiences of clinical exome sequencing. Journal of Genetic Counseling 29 (4):574–86. doi:10.1002/jgc4.1276.
  • Macnew, H. G., R. Rudolph, S. T. Brower, A. N. Beck, and E. A. Meister. 2010. Assessing the knowledge and attitudes regarding genetic testing for breast cancer risk in our region of Southeastern Georgia. The Breast Journal 16 (2):189–92. doi:10.1111/j.1524-4741.2009.00880.x.
  • Marcheco-Teruel, B., and E. Fuentes-Smith. 2009. Attitudes and knowledge about genetic testing before and after finding the disease-causing mutation among individuals at high risk for familial, early-onset Alzheimer’s disease. Genetic Testing and Molecular Biomarkers 13 (1):121–5. doi:10.1089/gtmb.2008.0047.
  • Marteau, T. M., E. Dormandy, and S. Michie. 2001. A measure of informed choice. Health Expectations 4 (2):99–108. doi:10.1046/j.1369-6513.2001.00140.x.
  • Matthews, A. K., S. Cummings, S. Thompson, V. Wohl, M. List, and O. I. Olopade. 2000. Genetic testing of African Americans for susceptibility to inherited cancers. Journal of Psychosocial Oncology 18 (2):1–19. doi:10.1300/J077v18n02_01.
  • Metcalfe, A., J. Werrett, L. Burgess, C. Chapman, and C. Clifford. 2009. Cancer genetic predisposition: Information needs of patients irrespective of risk level. Familial Cancer 8 (4):403–12. doi:10.1007/s10689-009-9256-6.
  • Michie, S., E. Dormandy, and T. M. Marteau. 2003. Informed choice: Understanding knowledge in the context of screening uptake. Patient Education and Counseling 50 (3):247–53. doi:10.1016/s0738-3991(03)00044-2.
  • Ngene, S. O., B. Adedokun, P. Adejumo, and O. Olopade. 2018. Breast cancer genetics knowledge and testing intentions among nigerian professional women. Journal of Genetic Counseling 27 (4):863–73. doi:10.1007/s10897-017-0194-4.
  • Olaya, W., P. Esquivel, J. H. Wong, J. W. Morgan, A. Freeberg, S. Roy-Chowdhury, and S. S. Lum. 2009. Disparities in BRCA testing: When insurance coverage is not a barrier. American Journal of Surgery 198 (4):562–5. doi:10.1016/j.amjsurg.2009.07.003.
  • Olejniczak, D., P. Dera, U. Religioni, A. Duda-Zalewska, and A. Deptała. 2016. Acceptance of, inclination for, and barriers in genetic testing for gene mutations that increase the risk of breast and ovarian cancers among female residents of Warsaw. Contemporary Oncology 20 (1):80–5. doi:10.5114/wo.2016.58504.
  • Ong, R., D. Howting, A. Rea, H. Christian, P. Charman, C. Molster, G. Ravenscroft, and N. G. Laing. 2018. Measuring the impact of genetic knowledge on intentions and attitudes of the community towards expanded preconception carrier screening. Journal of Medical Genetics 55 (11):744–52. doi:10.1136/jmedgenet-2018-105362.
  • Ormond, K. E., M. Iris, S. Banuvar, J. Minogue, G. J. Annas, and S. Elias. 2007. What do patients prefer: Informed consent models for genetic carrier testing. Journal of Genetic Counseling 16 (4):539–50. doi:10.1007/s10897-007-9094-3.
  • Peters, N., S. M. Domchek, A. Rose, R. Polis, J. Stopfer, and K. Armstrong. 2005. Knowledge, attitudes, and utilization of BRCA1/2 testing among women with early-onset breast cancer. Genetic Testing 9 (1):48–53. doi:10.1089/gte.2005.9.48.
  • Potter, B. K., N. O’Reilly, H. Etchegary, H. Howley, I. D. Graham, M. Walker, D. Coyle, Y. Chorny, M. Cappelli, I. Boland, et al. 2008. Exploring informed choice in the context of prenatal testing: Findings from a qualitative study. Health Expectations 11 (4):355–65. doi:10.1111/j.1369-7625.2008.00493.x.
  • Propst, L., G. Connor, M. Hinton, T. Poorvu, and J. Dungan. 2018. Pregnant women’s perspectives on expanded carrier screening. Journal of Genetic Counseling 27 (5):1148–56. doi:10.1007/s10897-018-0232-x.
  • Quaid, K. A., and M. Morris. 1993. Reluctance to undergo predictive testing: The case of Huntington disease. American Journal of Medical Genetics 45 (1):41–5. 5. doi:10.1002/ajmg.1320450112.
  • Rapp, R. 2000. Testing women, testing the fetus. London: Routledge.
  • Reid, B., M. Sinclair, O. Barr, F. Dobbs, and G. Crealey. 2009. A meta-synthesis of pregnant women’s decision-making processes with regard to antenatal screening for Down syndrome. Social Science & Medicine (1982) 69 (11):1561–73. doi:10.1016/j.socscimed.2009.09.006.
  • Roberts, M. C., J. M. Taber, and W. M. Klein. 2018. Engagement with genetic information and uptake of genetic testing: The role of trust and personal cancer history. Journal of Cancer Education 33 (4):893–900. doi:10.1007/s13187-016-1160-9.
  • Rubel, M. A., A. Werner-Lin, F. K. Barg, and B. A. Bernhardt. 2017. Expert knowledge influences decision-making for couples receiving positive prenatal chromosomal microarray testing results. Culture, Medicine and Psychiatry 41 (3):382–406. doi:10.1007/s11013-017-9521-3.
  • Salema, D., A. Townsend, and J. Austin. 2019. Patient decision-making and the role of the prenatal genetic counselor: An exploratory study. Journal of Genetic Counseling 28 (1):155–63. doi:10.1002/jgc4.1049.
  • Salkovskis, P. M., K. A. Rimes, J. Bolton, and A. L. Wroe. 2010. An experimental investigation of factors involved in the decision to undertake genetic testing for schizophrenia. Journal of Mental Health 19 (2):202–10. doi:10.3109/09638230903469160.
  • Samuel, G. N., S. Dheensa, B. Farsides, A. Fenwick, and A. Lucassen. 2017. Healthcare professionals’ and patients’ perspectives on consent to clinical genetic testing: Moving towards a more relational approach. BMC Medical Ethics 18 (1):47. doi:10.1186/s12910-017-0207-8.
  • Sankar, P., P. R. Wolpe, N. L. Jones, and M. Cho. 2006. How do women decide? accepting or declining BRCA1/2 testing in a Nationwide Clinical Sample in the United States. Community Genetics 9 (2):78–86. doi:10.1159/000091484.
  • Schwartz, M. D., B. N. Peshkin, K. P. Tercyak, K. L. Taylor, and H. Valdimarsdottir. 2005. Decision making and decision support for hereditary breast-ovarian cancer susceptibility. Health Psychology 24 (4S):S78–S84. doi:10.1037/0278-6133.24.4.S78.
  • Sheppard, V. B., K. D. Graves, J. Christopher, A. Hurtado-de-Mendoza, C. Talley, and K. P. Williams. 2014. African American women’s limited knowledge and experiences with genetic counseling for hereditary breast cancer. Journal of Genetic Counseling 23 (3):311–22. doi:10.1007/s10897-013-9663-6.
  • Skirton, H., L. Q. Frazier, A. O. Calvin, and M. Z. Cohen. 2006. A legacy for the children–attitudes of older adults in the United Kingdom to genetic testing. Journal of Clinical Nursing 15 (5):565–73. doi:10.1111/j.1365-2702.2006.01372.x.
  • Skirton, H., K. Murakami, M. Ito, S. Nakagomi, and H. Iino. 2008. A report of two linked studies of knowledge and attitudes to prenatal screening and testing in adults of reproductive age in Japan and the UK. Midwifery 24 (3):270–80. doi:10.1016/j.midw.2006.10.009.
  • Struewing, J. P., C. Lerman, and R. G. Kase. 1995. Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiology, Biomarkers & Prevention 4:169173.
  • Sun, S., S. T. Li, and J. Ngeow. 2020. Factors shaping at-risk individuals’ decisions to undergo genetic testing for cancer in Asia. Health & Social Care in the Community 28 (5):1569–77. doi:10.1111/hsc.12981.
  • Sussner, K. M., H. S. Thompson, L. Jandorf, T. A. Edwards, A. Forman, K. Brown, N. Kapil-Pair, D. H. Bovbjerg, M. D. Schwartz, and H. B. Valdimarsdottir. 2009. The influence of acculturation and breast cancer-specific distress on perceived barriers to genetic testing for breast cancer among women of African descent. Psycho-oncology 18 (9):945–55. doi:10.1002/pon.1492.
  • Tercyak, K. P., S. Hensley Alford, K. M. Emmons, I. M. Lipkus, B. S. Wilfond, and C. M. McBride. 2011. Parents’ attitudes toward pediatric genetic testing for common disease risk. Pediatrics 127 (5):e1288–e1295. doi:10.1542/peds.2010-0938.
  • Tessaro, I., N. Borstelmann, K. Regan, B. K. Rimer, and E. Winer. 1997. Genetic testing for susceptibility to breast cancer: Findings from women’s focus groups. Journal of Women’s Health 6 (3):317–27. doi:10.1089/jwh.1997.6.317.
  • Vadaparampil, S. T., J. McIntyre, and G. P. Quinn. 2010. Awareness, perceptions, and provider recommendation related to genetic testing for hereditary breast cancer risk among at-risk Hispanic women: Similarities and variations by sub-ethnicity. Journal of Genetic Counseling 19 (6):618–29. doi:10.1007/s10897-010-9316-y.
  • Vadaparampil, S. T., G. P. Quinn, J. Dutil, M. Puig, T. L. Malo, J. McIntyre, R. Perales, E. M. August, and Z. Closser. 2011. Dec A pilot study of knowledge and interest of genetic counseling and testing for hereditary breast and ovarian cancer syndrome among Puerto Rican women. Journal of Community Genetics 2 (4):211–21. doi:10.1007/s12687-011-0058-9.
  • Valdrez, K., S. Silva, T. Coelho, and E. Alves. 2014. Awareness and motives for use and non-use of preimplantation genetic diagnosis in familial amyloid polyneuropathy mutation carriers. Prenatal Diagnosis 34 (9):886–92. doi:10.1002/pd.4388.
  • Van Den Berg, M.,D. R. M. Timmermans,L. P. Ten Kate,J. M. G. Van Vugt, andG. Van Der Wal. 2005. Are pregnant women making informed choices about prenatal screening?. Genetics in Medicine: Official Journal of the American College of Medical Genetics 7 (5):332–8. doi:10.1097/01.gim.0000162876.65555.ab.
  • Viberg, J., P. Segerdahl, S. Langenskiöld, and M. G. Hansson. 2016. Freedom of choice about incidental findings can frustrate participants’ true preferences. Bioethics 30 (3):203–9. doi:10.1111/bioe.12160.
  • Wang, C., R. Gonzalez, N. K. Janz, K. J. Milliron, and S. D. Merajver. 2007. The role of cognitive appraisal and worry in BRCA1/2 testing decisions among aclinic population. Psychology & Health 22 (6):719–36. doi:10.1080/14768320600976216.
  • Wilson, J. L., G. M. Ferguson, and J. M. Thorn. 2011. Genetic testing likelihood: The impact of abortion views and quality of life information on women’s decisions. Journal of Genetic Counseling 20 (2):143–56. doi:10.1007/s10897-010-9335-8.
  • Wolff, K., K. Nordin, W. Brun, G. Berglund, and G. Kvale. 2011. Affective and cognitive attitudes, uncertainty avoidance and intention to obtain genetic testing: An extension of the Theory of Planned Behaviour. Psychology & Health 26 (9):1143–55. doi:10.1080/08870441003763253.
  • Young, A. L., P. N. Butow, K. M. Tucker, R. Williams, E. Healey, and C. E. Wakefield. 2019. Health professional and at-risk BRCA young adult perspectives about information needs: What does Gen Y need to know? Journal of Genetic Counseling 28 (6):1154–65. doi:10.1002/jgc4.1167.
  • Yu, J. 2012. A systematic review of issues around antenatal screening and prenatal diagnostic testing for genetic disorders: Women of Asian origin in western countries. Health & Social Care in the Community 20 (4):329–46. doi:10.1111/j.1365-2524.2011.01036.x.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.